ATE179888T1 - Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure - Google Patents

Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure

Info

Publication number
ATE179888T1
ATE179888T1 AT96118114T AT96118114T ATE179888T1 AT E179888 T1 ATE179888 T1 AT E179888T1 AT 96118114 T AT96118114 T AT 96118114T AT 96118114 T AT96118114 T AT 96118114T AT E179888 T1 ATE179888 T1 AT E179888T1
Authority
AT
Austria
Prior art keywords
dry eye
acid
sulfodehydroabic
prevention
treatment
Prior art date
Application number
AT96118114T
Other languages
English (en)
Inventor
Takahiro Ogawa
Noriko Watanabe
Yasushi Okumura
Original Assignee
Tanabe Seiyaku Co
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co, Senju Pharma Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of ATE179888T1 publication Critical patent/ATE179888T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT96118114T 1995-11-15 1996-11-12 Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure ATE179888T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7322364A JP3059092B2 (ja) 1995-11-15 1995-11-15 ドライアイおよびドライアイを原因とする疾患の予防・治療剤

Publications (1)

Publication Number Publication Date
ATE179888T1 true ATE179888T1 (de) 1999-05-15

Family

ID=18142826

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96118114T ATE179888T1 (de) 1995-11-15 1996-11-12 Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure

Country Status (11)

Country Link
US (1) US5830913A (de)
EP (1) EP0774254B1 (de)
JP (1) JP3059092B2 (de)
KR (1) KR100425354B1 (de)
CN (1) CN1078464C (de)
AT (1) ATE179888T1 (de)
CA (1) CA2190303C (de)
DE (1) DE69602412T2 (de)
ES (1) ES2131373T3 (de)
SG (1) SG42446A1 (de)
TW (1) TW411275B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
JP4982643B2 (ja) * 2000-09-14 2012-07-25 株式会社林原 眼科用医薬組成物
DE10045343B4 (de) * 2000-09-14 2005-05-12 Neuhann, Tobias, Dr.med. Verwendung einer wässrigen Lösung oder Suspension zum Heilen des Hornhautepithels
JP3945625B2 (ja) 2001-03-30 2007-07-18 株式会社イーエムアイ 角膜上皮障害モデル動物及びそのモデル動物を用いた薬剤の評価方法並びにその評価方法を用いて選択された薬剤
US6831101B2 (en) * 2001-06-14 2004-12-14 Chemokine Therapeutics Corporation Tricyclic rantes receptor ligands
CN1219757C (zh) * 2001-07-16 2005-09-21 中国医药研究开发中心有限公司 磺化去氢松香酸盐及其制备方法和其用途
TWI227137B (en) * 2001-09-27 2005-02-01 Tanabe Seiyaku Co Aqueous solution of ecabet sodium
US20040220089A1 (en) * 2001-10-03 2004-11-04 Ellis Edward J. Ophthalmic preparation containing glycoprotein
US20050137166A1 (en) * 2003-12-19 2005-06-23 Alcon, Inc. Use of cooling agents to relieve mild ocular irritation and enhance comfort
EP1757603A4 (de) * 2004-05-11 2008-06-25 Santen Pharmaceutical Co Ltd Therapeutisches mittel für keratokonjunktiva-erkrankungen
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
US8343942B2 (en) * 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
EP2389939A1 (de) * 2010-05-28 2011-11-30 Novagali Pharma S.A. Verwendung von Prostaglandinen F2alpha und Analoga zur Heilung von Horn- und Bindehautläsionen
US20130209531A1 (en) * 2010-06-08 2013-08-15 University Of Utah Research Foundation Applications of partially and fully sulfated hyaluronan
AU2011327785A1 (en) * 2010-11-08 2013-03-07 Healor Ltd. Buffered ophthalmic compositions and methods of use thereof
AU2011347237A1 (en) * 2010-12-21 2013-07-11 Recopharma Ab Tear substitutes
KR101438744B1 (ko) * 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
JP6110037B2 (ja) 2015-01-16 2017-04-05 生化学工業株式会社 コンドロイチン硫酸架橋体、並びにこれを含有する組成物、及び眼疾患処置剤
CN106581035A (zh) * 2016-12-06 2017-04-26 郑州郑先医药科技有限公司 一种治疗干眼病的西药组合物
CN106420797A (zh) * 2016-12-06 2017-02-22 郑州郑先医药科技有限公司 一种治疗干眼病的西药组合及其制备方法
US11229549B2 (en) * 2019-09-18 2022-01-25 Vance M. Thompson Tear transplantation and multi-part contact lens with absorbent portion
CN114588250B (zh) * 2022-03-18 2024-01-09 宁夏杞肽科技有限公司 枸杞糖肽在制备预防或治疗干眼症的药物中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2107584A (en) 1981-10-22 1983-05-05 Tanabe Seiyaku Co Treatment of gastro-intestinal diseases
GB2114975B (en) * 1981-10-22 1985-06-05 Tanabe Seiyaku Co Salts of sulfodehydroabietic acid and treatment of gastro-intestinal diseases
US5545617A (en) * 1993-11-12 1996-08-13 The Schepens Eye Research Institute, Inc. Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion

Also Published As

Publication number Publication date
SG42446A1 (en) 1997-08-15
KR970025612A (ko) 1997-06-24
DE69602412T2 (de) 1999-11-18
US5830913A (en) 1998-11-03
JP3059092B2 (ja) 2000-07-04
CA2190303A1 (en) 1997-05-16
EP0774254B1 (de) 1999-05-12
CN1078464C (zh) 2002-01-30
JPH09136832A (ja) 1997-05-27
CA2190303C (en) 2007-01-16
KR100425354B1 (ko) 2004-06-30
CN1159323A (zh) 1997-09-17
TW411275B (en) 2000-11-11
ES2131373T3 (es) 1999-07-16
MX9605633A (es) 1998-05-31
DE69602412D1 (de) 1999-06-17
EP0774254A1 (de) 1997-05-21

Similar Documents

Publication Publication Date Title
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
DE69633613D1 (de) 2-Amino-2-(2-(4-octylphenyl)ethyl)propan-1,3-diol enthaltendes Arzneimittel zur topischen Anwendung zur Behandlung von Erkrankungen die durch eine Störung des Immunsystems hervorgerufen werden
DE10299034I1 (de) Formulierung zur topischen Anwendung am Auge die olopatadine enthalten zur Behandlung von allergischen Augenerkrankungen
ATE175348T1 (de) L - deprenyl zur behandlung von makulärer degeneration
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
DE59508961D1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
DK164441C (da) Anvendelse af et piperidinderivat til fremstilling af et farmaceutisk praeparat til behandling af smertetilstande
ATE265851T1 (de) Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden
ATE157871T1 (de) Arzneimittel zur therapeutischen und prophylaktischen behandlung von krankheiten, die durch hyperplasie der glatten muskelzellen bedingt sind
DE69013431D1 (de) Anthocyanidine zur Behandlung von Augenkrankheiten.
KR930019224A (ko) 유산 위험 치료제
DE69011130D1 (de) Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen.
DE68916651D1 (de) Heilmittel zur behandlung von toxoplasmose.
DE69525631D1 (de) Verwendung von prostaglandinen zur herstellung eines arzneimittels zur prävention und behandlung des sekundären katarakts
DE68916443D1 (de) Arzneimittel zur behandlung von kryptosporidiose.
NO961496L (no) Behandling av allergiske sykdommer med terfenadinkarboksylat
DE69833317D1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn